RSC Publishing


Publishing

 

Cover image for Highlights in Chemical Biology

Highlights in Chemical Biology

Chemical biology news from across RSC Publishing.



Rapid technique for prostate cancer diagnosis


05 March 2009

A fast way to measure biomarkers in the body could help in diagnosing prostate cancer, says a team of UK and US scientists. The test needs only a small amount of sample and takes less than three minutes to complete.

David Parker, at Durham University, led the team that developed the method, which measures levels of citrate and lactate in bodily fluids. These are important markers for disease, explains Parker. Anions such as citrate and lactate are formed in cell metabolism processes which alter when cancers grow - citrate levels in prostate fluid fall as prostate cancer progresses.

A europium complex and prostate cancer cells

Lactate and citrate can be measured as they bind to europium complexes bringing about a change in luminescence

The team's measurements are derived from tests based on citrate and lactate anion binding to a series of luminescent europium complexes. The complexes showed different binding affinities for the anions, two with particularly good selectivity for either citrate or lactate. The researchers analysed changes in the complexes' emission intensities on binding and, by creating calibration curves relating anion levels to intensity, they could use the complexes' responses to samples to measure anion levels in fluids such as urine and prostate fluid.

The team compared its findings with results obtained using current enzyme methods of measuring citrate and lactate. These methods require longer sample preparation times and larger amounts of sample than Parker's sensing route, which showed similar results.

"This is a convenient and quick method which provides early warning of prostate cancer which will bring relief to many men"
- A Prasanna de Silva
 A Prasanna de Silva, chair of organic chemistry at Queen's University Belfast, UK, explains that Parker's team has drawn on its experience of anion sensing with lanthanide complexes to create the systems, which respond differently to citrate and lactate. 'This is a convenient and quick method which provides early warning of prostate cancer which will bring relief to many men,' he says.

Parker says the work is currently being evaluated for commercial use. 'Ultimately this could form the basis of a simple screening procedure that could be carried out in local surgeries up and down the country,' he suggests.

Katherine Davies

Enjoy this story? Spread the word using the 'tools' menu on the left or add a comment to the Chemistry World blog. 

Link to journal article

A europium luminescence assay of lactate and citrate in biological fluids
Robert Pal, David Parker and Leslie C. Costello, Org. Biomol. Chem., 2009, 7, 1525
DOI: 10.1039/b901251f

Also of interest

Prostate cancer biomarker could speed diagnosis

Testing urine for sarcosine may give new insights into prostate cancer diagnosis and progression

New twist on protein binding

A fortuitous discovery has led to a new type of probe for protein interactions that could find use in cellular imaging

Interview: A systematic future?

Leroy Hood talks to Katherine Vickers about Google, prions and the human genome project.